BioCentury
ARTICLE | Clinical News

Egen preclinical data

July 1, 2013 7:00 AM UTC

In a rat model of PAH, IV administration of a microRNA-145 inhibitor using Egen's Staramine-mPEG delivery system significantly reversed pulmonary hypertension and improved cardiovascular function. Da...